BlackRock Fund Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $48.5M | Buy |
1,447,002
+153,398
| +12% | +$5.14M | 0.01% | 1703 |
|
|
2016
Q3 | $34.4M | Buy |
1,293,604
+91,672
| +8% | +$2.44M | 0.01% | 1813 |
|
|
2016
Q2 | $26.5M | Buy |
1,201,932
+17,925
| +2% | +$395K | 0.01% | 1884 |
|
|
2016
Q1 | $34.8M | Buy |
1,184,007
+33,777
| +3% | +$992K | 0.01% | 1669 |
|
|
2015
Q4 | $38M | Sell |
1,150,230
-3,909
| -0.3% | -$129K | 0.01% | 1661 |
|
|
2015
Q3 | $41.7M | Buy |
1,154,139
+493,991
| +75% | +$17.9M | 0.01% | 1536 |
|
|
2015
Q2 | $29.7M | Buy |
660,148
+133,523
| +25% | +$6.01M | 0.01% | 1867 |
|
|
2015
Q1 | $16.1M | Buy |
526,625
+20,083
| +4% | +$615K | ﹤0.01% | 2182 |
|
|
2014
Q4 | $25.8M | Buy |
506,542
+257,293
| +103% | +$13.1M | 0.01% | 1909 |
|
|
2014
Q3 | $9.86M | Sell |
249,249
-5,457
| -2% | -$216K | ﹤0.01% | 2356 |
|
|
2014
Q2 | $11M | Buy |
254,706
+152,082
| +148% | +$6.55M | ﹤0.01% | 2363 |
|
|
2014
Q1 | $4.1M | Buy |
102,624
+2,844
| +3% | +$114K | ﹤0.01% | 2932 |
|
|
2013
Q4 | $2.72M | Sell |
99,780
-4,448
| -4% | -$121K | ﹤0.01% | 3094 |
|
|
2013
Q3 | $2.39M | Buy |
104,228
+12,384
| +13% | +$284K | ﹤0.01% | 3097 |
|
|
2013
Q2 | $1.63M | Buy |
+91,844
| New | +$1.63M | ﹤0.01% | 3124 |
|